Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIR
3626
DELISTED
CIRCOR International, Inc
CIR
| $953K | ﹤0.01% |
20,061
+12,406
| +162% | +$538K |
|
3627
PUT
Agilent Technologies
A
$41.9B
| $952K | ﹤0.01% |
13,500
-17,700
| -57% | -$1.17M |
|
3628
Kratos Defense & Security Solutions
KTOS
$11.8B
| $952K | ﹤0.01% |
64,384
+56,433
| +710% | +$746K |
|
3629
CALL
Signet Jewelers
SIG
$3.59B
| $949K | ﹤0.01% |
14,400
-31,100
| -68% | -$1.92M |
|
3630
CALL
IMAX
IMAX
$2.81B
| $947K | ﹤0.01% |
36,700
+16,700
| +84% | +$393K |
|
|
ONC
3631
BeOne Medicines Ltd
ONC
$40.6B
| $947K | ﹤0.01% |
5,497
+5,491
| +91,517% | +$923K |
|
3632
BJs Wholesale Club
BJ
$11.8B
| $946K | ﹤0.01% |
35,343
+34,143
| +2,845% | +$914K |
|
3633
CALL
Coherent
COHR
$64B
| $946K | ﹤0.01% |
20,000
-9,200
| -32% | -$418K |
|
3634
UroGen Pharma
URGN
$2.39B
| $945K | ﹤0.01% |
20,000
-2,600
| -12% | -$121K |
|
|
INFN
3635
DELISTED
Infinera Corporation Common Stock
INFN
| $943K | ﹤0.01% |
129,378
+80,658
| +166% | +$685K |
|
|
KEM
3636
PUT
DELISTED
KEMET Corporation
KEM
| $942K | ﹤0.01% |
50,800
+33,200
| +189% | +$817K |
|
3637
PUT
Ironwood Pharmaceuticals
IRWD
$714M
| $941K | ﹤0.01% |
60,894
+59,700
| +5,000% | +$944K |
|
3638
CALL
Quest Diagnostics
DGX
$26.2B
| $939K | ﹤0.01% |
8,700
-12,800
| -60% | -$1.4M |
|
3639
Ormat Technologies
ORA
$6.97B
| $935K | ﹤0.01% |
17,275
-1,900
| -10% | -$101K |
|
|
CHL
3640
PUT
DELISTED
China Mobile Limited
CHL
| $935K | ﹤0.01% |
19,100
-16,800
| -47% | -$776K |
|
3641
CALL
FMC
FMC
$1.28B
| $933K | ﹤0.01% |
12,337
-1,038
| -8% | -$78.2K |
|
|
CRAY
3642
DELISTED
Cray, Inc.
CRAY
| $933K | ﹤0.01% |
43,357
+23,935
| +123% | +$552K |
|
3643
Axogen
AXGN
$2.67B
| $930K | ﹤0.01% |
25,240
+20,731
| +460% | +$905K |
|
3644
CALL
Ventas
VTR
$45.7B
| $930K | ﹤0.01% |
17,100
-35,200
| -67% | -$2.04M |
|
3645
PUT
Eastman Chemical
EMN
$8.29B
| $928K | ﹤0.01% |
9,700
+900
| +10% | +$89.2K |
|
|
NOAH
3646
Noah Holdings
NOAH
$588M
| $928K | ﹤0.01% |
22,021
+13,221
| +150% | +$603K |
|
|
HCR
3647
PUT
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $928K | ﹤0.01% |
85,900
-31,400
| -27% | -$394K |
|
3648
Acco Brands
ACCO
$399M
| $927K | ﹤0.01% |
82,005
+23,469
| +40% | +$301K |
|
3649
CALL
Shake Shack
SHAK
$2.94B
| $926K | ﹤0.01% |
14,700
-89,100
| -86% | -$5.41M |
|
|
MAGN
3650
Magnera Corp
MAGN
$443M
| $925K | ﹤0.01% |
3,721
+2,493
| +203% | +$608K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.